Progressive rubella panencephalitis: clinical course and response to 'isoprinosine'.
This report describes the clinical course of a 16-year-old Canadian-born Chinese boy who has progressive rubella panencephalitis. The progression, the lack of response to 'Isoprenosine', and the additional finding of myopathy are discussed. The clinical and pathological features of this rare, progressive neurological disorder are also summarized. In view of the last major rubella pandemic occuring in the mid-60s, it is likely that during the next few years physicians will diagnose an increased number of patients with this distinct neurological entity.
D000293:Adolescent; D000914:Antibodies, Viral / Q000032:analysis; D003168:Complement Fixation Tests; D004568:Electrodiagnosis; D004660:Encephalitis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D007288:Inosine / Q000031:analogs & derivatives*; D007542:Inosine Pranobex / Q000627:therapeutic use*; D008297:Male; D012409:Rubella / Q000150:complications* / Q000188:drug therapy
D000914:Antibodies, Viral; D007288:Inosine; D007542:Inosine Pranobex